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Acetylcholine is synthesized in the cytoplasm of cholinergic neurons through the action of the enzyme choline acetyltransferase, and is then transported into small synaptic vesicles by the vesicular acetylcholine transporter (VAChT) (1). Acetylcholine (ACh) transport involves the exchange of two luminal protons for each molecule of cytoplasmic transmitter transported into the vesicle (2-4). The driving force for transport is derived from a proton electrochemical gradient across the vesicular membrane generated by a vacuolar type H + -ATPase located on the synaptic vesicle (5, 6) .
The filled vesicles release their contents through exocytosis, producing an action potential at the nerve terminal (7) . As a consequence of this process
VAChT is transported with the synaptic vesicle to the plasma membrane where it fuses with the plasma membrane. Synaptic vesicles and their component proteins, including VAChT, are recycled from the plasma membrane back to the synaptic vesicle by endocytosis via an endosomal compartment (8) . This cycle is critical for neurotransmission, and it appears that newly synthesized synaptic vesicle proteins are transported to the plasma membrane even before they reach the synaptic vesicle (9) . Evidence has been obtained that the cytoplasmic tail of VAChT contains the signal(s) which traffic it to the synaptic vesicle (10) .
VAChT cDNAs have recently been cloned from a number of sources including the nematode Caenorhabditis elegans (11) , the electric marine ray
Torpedo (12) , rat brain stem, and rat neuroendocrine PC12 cells, and the human neuroblastoma SK-N-SH cell line (13, 14) . The amino acid sequence of VAChT has revealed that it belongs to a family of transporters which includes the monoamine transporters VMAT1 and VMAT2. This family of 4 transporters can be characterized as containing 12 transmembrane domains, an N-linked glycosylated loop located between transmembrane domains 1 and 2, and cytoplasmic N and C terminal domains (13) . The twelve transmembrane domains are highly conserved and maintain native conformation of the transporters (4) . In contrast, the cytoplasmic amino and carboxyl terminal domains are rather divergent (4).
It has recently been shown that VMAT2 can be phosphorylated by casein kinase I, and possibly casein kinase II, on two serine residues, serine 512 and serine 514, located on the C-terminal cytoplasmic tail (15) . These serine residues are not conserved in VAChT, and thus the question of whether or not VAChT is also phosphorylated on the C-terminal cytoplasmic tail or elsewhere has been addressed in this study. We utilized a mutant PC12 cell line, PC12 A123.7 , which has reduced levels of protein kinase A type I and type II activity (16) , and as a consequence VAChT gene transcription is reduced (17) such that VAChT protein is undetectable. On the other hand, PC12 A123.7 contains synaptic vesicles which can be reconstituted with recombinant VAChT to produce a transport competent vesicle (18) . In this study this system has been used to demonstrate that rVAChT, like VMAT2, is phosphorylated on its C-terminal cytoplasmic domain. However, VAChT phosphorylation occurs at a distinct site and appears to be catalyzed by protein kinase C, rather than casein kinase II as is the case for VMAT2.
Studies of a VAChT species in which the phosphorylation site is removed by site-directed mutagenesis suggests that phosphorylation of rVAChT may play a role in trafficking of the transporter. (18) . PC12 cells were maintained at 37 o C in 10% CO 2 in Dulbecco's modified Eagle's medium containing 5% horse serum, 10% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. The PKA deficient PC12 cell line PC12 A123.7 was maintained in F-12 medium containing 5% horse serum, 10% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. PC12 A123.7/VAChT was cultured in the same media with 100 µg/ml of G418 added. immunoprecipitated with rabbit anti-rVAChT antisera as described above. pyridine) for the second dimension. After drying the plates, standards were stained with ninhydrin and the plates were exposed to a phosphorImager screen.
Isolation of Postnuclear supernatants and synaptic vesicles:
Postnuclear supernatants were isolated by differential centrifugation as previously described (18) . Briefly, cell pellets were harvested by centrifugation and suspended in 10 mM HEPES-KOH buffer, pH 7. this point we tested the effect of the casein kinase II inhibitor DRB on protein kinase C activity using a specific peptide substrate for protein kinase C (HPro-Leu-Ser-Arg-Thr-Leu-Ser-Bal-Ala-Ala-Lys-Lys-OH) (32) . We found that the casein kinase II inhibitor afforded partial inhibition (35%) in this assay.
We also tested the effect of the protein kinase C inhibitor on casein kinase II activity using the specific casein kinase II peptide substrate H-Arg-Arg-ArgAla-Asp-Asp-Ser-Asp-Asp-Asp-Asp-Asp-OH (33) . In this case there was no effect of the protein kinase C inhibitor on casein kinase II activity. This finding suggests that serine 480 is phosphorylated exclusively by protein kinase C.
We examined a number of potential functions of VAChT which might be affected by its phosphorylation. We first determined if phosphorylation might affect the kinetics of ACh transport by comparing the Km and Vmax for ACh transport between the wild type and S480A mutant. As shown in Table 1 , wild type VAChT transported ACh at a maximal rate of 126 pmols/min/mg protein with a Km for transport of 2.3 mM. The S480A mutant transported ACh at a maximal rate of 143 pmols/min/mg protein with a Km for transport of 2.7 mM. We do not consider these differences significant. The wild type transporter bound 1.9 pmol of vesamicol per mg protein, while the S480A mutant bound 2.0 pmol of vesamicol per mg protein.
We compared the targeting of the S480A mutant to synaptic vesicles to that of wild type VAChT. As shown in figure 7A and B, during sucrose density gradient centrifugation wild type VAChT co-migrates with synaptophysin (P38) used as a marker for synaptic vesicles. Secretogranin II,
Discussion
We have shown that rat VAChT can be phosphorylated in intact PC12
cells. We as well as others (34) It has been established that leucine based sorting motifs (L-motifs), usually composed of two successive leucines, are involved in internalization of receptors from the plasma membrane as well as the sorting of receptors from the TGN to endosomes/lysosomes (40-43). It has also been found that an acidic amino acid four or five residues amino terminal to the L-based sorting motif can be important for sorting (44, 45) . For the T-cell receptor subunit
CD3γ it was shown that internalization was dependent on phosphorylation of a serine five residues amino terminal to this motif (44) . Based on these studies it was proposed that there are three types of L-based sorting motifs;
one that is directly accessible to adaptor proteins, one that is part of a multi- In addition phosphoserine more often resembles an aspartate-like residue than a glutamate residue. The consequences of these differences may be twofold. On the one hand phosphorylation of VAChT on a residue involved in sorting may be regulated through a kinase/phosphatase cycle. Furthermore, since VMAT2 is sorted to large dense core vesicles while VAChT is sorted to small synaptic vesicles, the C-terminal cytoplasmic serine-phosphate of
VAChT and the corresponding C-terminal cytoplasmic glutamate of VMAT2 may serve as a part of a differential sorting signal. Le Borgne et al. (45) showed that serine phosphorylation on the cytoplasmic domain of the cation independent mannose 6-phosphate receptor is an essential feature for sorting this receptor to the TGN. Dephosphorylation of phosphorylated serine 480 of
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VAChT in the TGN could be a part of a sorting signal for trafficking to the small synaptic vesicle, while retention of the negative charge as a glutamate in VMAT2 could be the signal to traffic to the large dense core vesicle. In support of this suggestion is the finding made in this study that the S480A mutant of VAChT, which cannot be phosphorylated, is mis-sorted in the mutant PC12 cell line. Whether this is a unique phenomena in PC12 cells or can be generalized to cholinergic neurons must await further experimentation. 
